Annexon (ANNX) Research & Development (2019 - 2026)

Annexon's (ANNX) quarterly Research & Development came in at $35.8 million in Q1 2026, down 25.72% year-on-year from $48.2 million in Q1 2025, and down 16.11% quarter-over-quarter from $42.7 million in Q4 2025.

Annexon (ANNX) Research & Development (2019 - 2026) Analysis & Trends

Annexon's Research & Development history runs 8 years deep, the most recent figure standing at $35.8 million for Q1 2026.

  • On a quarterly basis, Research & Development fell 25.72% year-over-year to $35.8 million in Q1 2026; TTM through Mar 2026 was $172.3 million, a 17.48% increase from a year earlier, with the FY2025 full-year figure at $184.7 million, up 54.63% from the prior year.
  • Research & Development eased to $35.8 million in Q1 2026 per ANNX's latest filing, from $42.7 million in the prior quarter.
  • Across five years, Research & Development topped out at $49.7 million in Q3 2025 and bottomed at $21.0 million in Q1 2024.
  • The 5-year median for Research & Development is $30.1 million (2024), against an average of $33.3 million.
  • Across the five-year window, Research & Development sank 35.19% in 2024 and soared 129.83% in 2025, its largest moves.
  • Year by year, Research & Development stood at $28.5 million in 2022, then dropped by 18.46% to $23.3 million in 2023, then surged by 86.33% to $43.4 million in 2024, then declined by 1.6% to $42.7 million in 2025, then decreased by 16.11% to $35.8 million in 2026.
  • Per Business Quant, the three latest ANNX Research & Development figures stand at $35.8 million (Q1 2026), $42.7 million (Q4 2025), and $49.7 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -17.94 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 1.46 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 541.22 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 961.60 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 1.54 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - 15.66 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -443.00 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - 343.97 Mn
10 Annexon 1.02 Bn 798.41 Mn - 35.79 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 35.79 Mn
Dec 31, 2025 42.66 Mn
Sep 30, 2025 49.70 Mn
Jun 30, 2025 44.16 Mn
Mar 31, 2025 48.18 Mn
Dec 31, 2024 43.35 Mn
Sep 30, 2024 30.11 Mn
Jun 30, 2024 25.03 Mn
Mar 31, 2024 20.96 Mn
Dec 31, 2023 23.27 Mn
Sep 30, 2023 27.89 Mn
Jun 30, 2023 30.25 Mn
Mar 31, 2023 32.35 Mn
Dec 31, 2022 28.54 Mn
Sep 30, 2022 27.86 Mn
Jun 30, 2022 29.11 Mn
Mar 31, 2022 27.00 Mn
Dec 31, 2021 27.22 Mn
Sep 30, 2021 27.58 Mn
Jun 30, 2021 24.57 Mn